002044 Meinian Onehealth Healthcare Holdings
- 4.53
- 0.000.00%
Meinian Onehealth Healthcare Holdings News
American Health (002044): The annual business trend is improving, and data assets have begun to be included in the table
Event: American Health released its 2023 annual report on April 25: the company achieved revenue of 10.9 billion yuan (+26%, year-on-year scale, same below); net profit to mother of 506 million yuan (+190%), returned in 2022
American Health (002044): The trend of increasing customer unit prices in 2023 is evident, and performance is growing strongly
Announcement: American Health released its 2023 annual report, 2024 quarterly report, strong growth in 2023 performance, and a significant increase in profitability. 2023 operating income of 10.89 billion yuan (+26.4%), net profit to mother
American Health (002044.SZ) reported first-quarter results with a net loss of 287 million yuan
American Health (002044.SZ) released its report for the first quarter of 2024. The company achieved operating income during the reporting period...
American Health (002044): 2023 results are in line with market expectations, profit side turned loss into profit
The 2023 results are in line with market expectations, and Mei Nian Health announced the 2023 results: revenue of 10.89 billion yuan, an increase of 26.4% over the previous year; net profit to mother of 510 million yuan, corresponding to profit of 0.13 yuan per share; deducted net income from non-return to mother
American Health (002044): Performance is in line with expectations, the medical examination industry continues to expand, and performance volume and price rise sharply
Incident: In 2023, revenue of 10.894 billion yuan (+26.44%) was achieved, net profit attributable to mother was 506 million yuan, and net profit of non-return to mother was 463 million yuan, turning a loss into a profit. 2023Q4 Achieving Revenue 36
American Health (002044): Strong rise in volume and price, leading performance growth, development prospects can be expected
Performance Brief Review On April 24, 2024, the company released its 2023 annual report. In 2023, the company achieved revenue of 10.89 billion yuan (+26.4%, year-on-year, same below); realized net profit of 5.06 billion yuan to mother
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to p
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to promote performance growth; 2) digital operation enables development, and the layout of AI continues to innovate. (Mainichi Keizai Shimbun)
Nugget AI just when American Health's 2023 revenue exceeded 10.8 billion yuan
On the evening of April 24, Meinian Health Industry Holdings Co., Ltd. (hereinafter referred to as “American Health”, 002044.SZ) released its 2023 annual report showing that the company achieved operating income of 10.894 billion yuan, an increase of 26.44%; net profit to the mother of 506 million yuan, an increase of 1,065 million yuan over the same period of the previous year; total number of visitors increased 13.0% year on year, comprehensive customer unit price increased 11.2% year on year, and achieved strong growth in the first year of post-epidemic recovery. The company said that in 2024, it will adhere to a firm quality and efficiency orientation and adhere to “sustainable growth driven by digital intelligence, diversified growth and high quality profits
American Health (002044.SZ) announced its 2023 annual results, with net profit of 506 million yuan, turning a loss into a profit
According to Zhitong Finance App News, American Health (002044.SZ) released its 2023 annual report. The company's operating income was 10.894 billion yuan, an increase of 26.44% over the previous year; net profit attributable to shareholders of listed companies was 506 million yuan, which turned a loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 463 million yuan, which turned a loss into a profit; basic earnings per share were 0.13 yuan/share. It is proposed to distribute a cash dividend of 0.19 yuan (tax included) for every 10 shares to all shareholders.
Express News | American Health: Net profit due to mother in 2023 was 506 million yuan, an increase of 190.45% year-on-year
American Health's “All in AI” enters the golden track of “AI+ Healthcare”
Health management robots are here, and the big domestic healthcare AI model has welcomed new samples. According to reports, on April 15 of this year, Meinian Health's new AI application product, the “Health Xiaomei” digital intelligence manager, began internal trial operation. According to official sources, this is the first AI robot for health management in China. Through this product, users can generate a health management plan adapted to their own with one click after uploading information such as personal lifestyle habits and exercise conditions; they can also obtain exclusive medical examinations and prevention plans based on personal health data, lifestyle habits, family medical history, etc. Simply put, using “Healthy and Little Beauty” is equivalent to having a 24-hour person
Express News | American Health released the first domestic AI robot for health management - “Health Xiaomei”
American Health (002044): Performance forecasts meet expectations, leading private medical examinations embark on a new journey
Incident On January 28, 2024, the company released the 2023 annual performance forecast. In 2023, it achieved operating income of 107.3 to 11.05 billion yuan (+25.75% to 29.50%) and achieved net profit to mother
American Health (002044) performance forecast review: Excellent performance in the fourth quarter and continued to increase innovative products and AI applications
Event: The company announced its 2023 performance forecast. It is expected to achieve operating income of 10.73 to 11.05 billion yuan (+25.7 to 29.5%) for the full year of 2023; net profit to mother of 4.6-570 billion yuan, of net profit to mother of net interest rate
American Health (002044): Revenue exceeded expectations, medical examination demand recovered as scheduled
Event: The company released its 2023 annual performance forecast. The company expects to achieve operating income of 10.73 billion yuan - 11.05 billion yuan in 2023, an increase of 25.8%-29.5% over the previous year, and net profit of 460 million yuan to mother
Express News | American Health: 2023 net profit of 460 million yuan - 570 million yuan, reversing year-on-year losses
Express News | American Health and Zhejiang University officially signed a contract to promote the “Healthy Zhejiang Million People Cohort” research project
Express News | American Health signs comprehensive cooperation agreements with HUAWEI CLOUD and Runda Healthcare
American Health (002044.SZ) plans to sign a genetic testing project cooperation agreement with Meiyin Health
American Health (002044.SZ) issued an announcement. The company held the 8th board of directors meeting on January 5, 2024...
American Health (002044.SZ) granted 66.542 million stock options to incentive recipients for the first time, with an exercise price of 4.29 yuan/share
American Health (002044.SZ) issued an announcement according to the “Administrative Measures on Equity Incentives for Listed Companies” and the Company's “2...
Analysis
Price Target
No Data
